Paul Mattels

Stock Analyst at Stifel

(n/a)

# 4,926

Out of 4,944 analysts

4

Total ratings

n/a

Success rate

-38.24%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Paul Mattels

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	DNLI Denali Therapeutics	Upgrades: Buy	$37	$14.37	+157.48%	3	Dec 16, 2024
	ALEC Alector	Initiates: Buy	$44	$2.08	+2,015.38%	1	Feb 19, 2020

Denali Therapeutics

Dec 16, 2024

Upgrades: Buy

Price Target: $37

Current: $14.37

Upside: +157.48%

Alector

Feb 19, 2020

Initiates: Buy

Price Target: $44

Current: $2.08

Upside: +2,015.38%